CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash flows from operating activities
Net income	$ 25,023	$ 10,166
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and share-based compensation	5,611	7,480
Net realized losses (gains) on investment	57	(2,457)
Foreign exchange (gains) losses	(2,414)	8,643
Changes in assets – (increase) decrease:
Reinsurance balances receivable, net	(126,242)	(84,743)
Reinsurance recoverable on unpaid losses	7,765	12,441
Accrued investment income	653	1,132
Deferred commission and other acquisition expenses	(33,340)	(49,773)
Other assets	(38,507)	(14,669)
Changes in liabilities – increase (decrease):
Reserve for loss and loss adjustment expenses	118,404	180,462
Unearned premiums	129,892	163,689
Accrued expenses and other liabilities	(30,798)	(8,824)
Net cash provided by operating activities	56,104	223,547
Cash flows from investing activities:
Purchases of fixed-maturities – available-for-sale	(529,247)	(260,963)
Purchases of other investments	0	(147)
Proceeds from sales of fixed-maturities – available-for-sale	301,690	102,394
Proceeds from maturities, paydowns and calls of fixed maturities – available-for-sale	194,045	205,606
Proceeds from maturities and calls of fixed maturities – held to maturity	56,788	7,856
Proceeds from sale and redemption of other investments	1,022	388
Other, net	(2,098)	(864)
Net cash provided by investing activities	22,200	54,270
Cash flows from financing activities:
Repurchase of common shares	(193)	(575)
Dividends paid – Maiden common shareholders	(24,924)	(25,936)
Dividends paid – preference shares	(17,091)	(12,066)
Preference shares, net of issuance costs	0	145,120
Redemption of 2012 senior notes	0	(100,000)
Issuance of common shares	0	1,010
Net cash (used in) provided by financing activities	(42,208)	7,553
Effect of exchange rate changes on foreign currency cash and cash equivalents and restricted cash and cash equivalents	(820)	2,391
Net increase in cash and cash equivalents and restricted cash and cash equivalents	35,276	287,761
Cash and cash equivalents and restricted cash and cash equivalents, beginning of period	191,503	149,535
Cash and cash equivalents and restricted cash and cash equivalents, end of period	226,779	437,296
Total cash and cash equivalents, and restricted cash and cash equivalents shown in the Condensed Consolidated Statements of Cash Flows, end of period	$ 191,503	$ 149,535